Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of YHP2205 and YHR2401 in Healthy Volunteers
NCT06775522Phase 1Completed
- Sponsor
- Yuhan
- Start
- Jan 2025
- Primary completion
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of YHP2205 (2 arms), sponsored by Yuhan. Primary endpoints: Area under the plasma drug concentration-time curve from time 0 to time t and Maximum plasma concentration. Started Jan 2025; status: completed.
02
Drugs
YHP2205
Beyond the preview
Go deeper on NCT06775522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06775522.